# Sodium phenylacetate and Sodium benzoate

NDC: 68475-513
Generic name: Sodium phenylacetate and Sodium benzoate
Labeler / Manufacturer: Navinta LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20251206

FDA application: ANDA217526

## Active ingredients

- SODIUM BENZOATE: 100 mg/mL
- SODIUM PHENYLACETATE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68475-513"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68475-513
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d20768fe-4516-483a-a082-ff1df9ad1d99